Part B drug prices suffer an overall decrease despite 280 price increases

Why This Topic Matters

Quarterly ASP updates can affect reimbursement, claim review, and charge capture for outpatient drug services under Medicare Part B. Readers who work with drug billing, payment analysis, or compliance need to monitor which drugs changed, which were removed, and which were added to the list.

Article Sections

1. Overview of third-quarter ASP pricing movement

   Summarizes the overall CMS update to the Part B Average Sales Price list for the third quarter of 2010. It describes broad trends in pricing changes and the general distribution of increases and decreases.

2. Key ASP changes for Part B drugs for the third quarter 2010

   Presents a table of drugs with notable quarter-to-quarter price movement. The section groups items into increases and decreases and reflects the CMS third-quarter pricing update.

3. Source and list notes

   Identifies the CMS ASP list source and notes the effective dates for the third-quarter prices. It also references list changes, including additions and removals.